26. Liraglutide Reverses Pronounced Insulin-Associated Weight Gain, Improves Glycemic Control, and Decreases Insulin Dose in Patients with Type 2 Diabetes (973-P)
Crossref DOI link: https://doi.org/10.1007/s12467-014-0051-0
Published Online: 2014-11-25
Published Print: 2014-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
de Wit, Helena
Vervoort, Gerald M.
Jansen, Henry J.
de Grauw, Wim J.C.
de Galan, Bastiaan E.
Tack, Cees J.
Text and Data Mining valid from 2014-10-01